Organigram Global Inc.

corporate_fare Company Profile

Organigram Global Inc.

OGI·NASDAQ·Life Sciences·CIK 0001620737

Organigram Global Inc. produces and sells cannabis and cannabis-derived products exclusively in Canada. The company offers a range of medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates. For the adult-use recreational market, Organigram Global Inc. sells products under various brands such as SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian. Beyond finished products, the company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. Its cannabis products are distributed through wholesale and retail channels within both the recreational and medical cannabis regulatory frameworks, and are also available for sale online. Organigram Global Inc. is headquartered in Toronto, Canada.

Organigram Global Inc. (NASDAQ:OGI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for OGI at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

Organigram Reports Strong Q1 Revenue & EBITDA Growth, Faces US Hemp Market Uncertainty (2026-02-10)

Financial Snapshot

Fiscal year ended September 30, 2025

Revenue

CA$259.18M CAD

Net Income

-CA$24.76M CAD

Diluted EPS

-CA$0.19 CAD

Op. Cash Flow

-CA$7.59M CAD

Free Cash Flow

-CA$24.61M CAD

Gross Profit

CA$90.22M CAD

Operating Income

-CA$15.3M CAD

Cash & Equivalents

CA$28.2M CAD

Total Debt

CA$25K CAD

Debt / Equity

0.00×

Net Margin

-9.6%

Shares Outstanding

134.46M sh

Source: 40-F · filed 2025-12-16 · accession 0001628280-25-057233

Insider Transactions

OGI files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

show_chartPrice Chart

Loading chart...

feed OGI - Filings & News (Page 2)

Filing Type

Date Range

OGI

Feb 10, 2026, 7:41 AM EST

Filing Type: 6-K

Importance Score:

Organigram Reports Strong Q1 Revenue & EBITDA Growth, Faces US Hemp Market Uncertainty

Price at Filing: $1.61

Real-time Price: $0.9325

Change: -$0.6775 (-42%)

Market Cap: $129.712M

Sentiment: Neutral

View Wiseek Article

Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets

corporate_fare Company Profile